BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16707426)

  • 1. Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.
    Zhang W; Chuang YJ; Jin T; Swanson R; Xiong Y; Leung L; Olson ST
    Cancer Res; 2006 May; 66(10):5047-55. PubMed ID: 16707426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
    Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.
    Zhang W; Chuang YJ; Swanson R; Li J; Seo K; Leung L; Lau LF; Olson ST
    Blood; 2004 Feb; 103(4):1185-91. PubMed ID: 14563633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene expression profiling of microvascular endothelial cells during capillary morphogenesis in an in vitro model of angiogenesis].
    Sun XT; Ding YT; Wu LY; Li Q; Cheng N; Qiu YD; Zhang MY
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):37-41. PubMed ID: 15774172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine inhibition of angiogenesis involves the transcription factor HESR1.
    Shah G; Middleton FA; Gentile KL; Tripathi S; Bruch D; Maier KG; Kittur DS
    J Surg Res; 2008 Oct; 149(2):171-6. PubMed ID: 18694572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses.
    Pfeffer U; Ferrari N; Dell'Eva R; Indraccolo S; Morini M; Noonan DM; Albini A
    Mutat Res; 2005 Dec; 591(1-2):198-211. PubMed ID: 16084531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
    Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide microarray analysis of human lens epithelial cells: TGFbeta regulated gene expression.
    Dawes LJ; Elliott RM; Reddan JR; Wormstone YM; Wormstone IM
    Mol Vis; 2007 Jul; 13():1181-97. PubMed ID: 17679943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
    Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
    Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells.
    Mazzanti CM; Tandle A; Lorang D; Costouros N; Roberts D; Bevilacqua G; Libutti SK
    Genome Res; 2004 Aug; 14(8):1585-93. PubMed ID: 15289477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
    Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
    J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis.
    Schubert-Unkmeir A; Sokolova O; Panzner U; Eigenthaler M; Frosch M
    Infect Immun; 2007 Feb; 75(2):899-914. PubMed ID: 17130252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic antithrombin.
    O'Reilly MS
    Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent in vivo antiangiogenic effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1.
    Al-Mahmood S; Colin S; Farhat N; Thorin E; Steverlynck C; Chemtob S
    J Pharmacol Exp Ther; 2009 May; 329(2):496-504. PubMed ID: 19208899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.